Phase 4 N=28 Treatment of Upper Extremity Deep-Vein Thrombosis
Deep-Vein Thrombosis
Primary: Percentage of Participants That Died at 3 Months — 8; 0 percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=165 Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer
Peptic Ulcer
Primary: Recurrent Peptic Ulcer — 1; 9 participants
Phase 3 N=537 Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Venous Leg Ulcer
Primary: Complete Healing of the Study Ulcer by Week 16. — 201; 176 participants — p=0.1030
N/A N=18 Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?
Food-drug Interaction
Primary: Primary Pharmacokinetic Measure: Area Under the Curve (AUC) — 4.2; 4.2; 4.2; 3.2 micromolar*hr — p=0.78
N/A N=20 The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
Major Depression
Primary: Wechsler Memory Scale-III (WMS-III) Auditory Delayed Index
Phase 3 N=92 Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)
Asthma
Primary: Juniper Asthma Control Questionnaire (ACQ) Results — -0.15; -0.38 units on a scale
N/A N=1,365 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Requiring General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on the Cardiovascular System in Common Clinical Practice
Anesthesia, General
Primary: Time to Loss of Consciousness of Patients Administered Anesthesia — 3.0 minutes
Phase 2 N=150 Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Ovarian Cancer
Primary: Progression-free Survival (PFS) — 13.7; 8.4 months
Phase 2 N=23 Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Glioblastoma · Gliosarcoma
Primary: The Primary Outcome Measure is 6 Month Progression-free Survival. — 0; 7.7 percentage of participants
Phase 3 N=60 Efficacy of Omija (Schisandra Chinensis) Extract in Subjects With Knee Osteoarthritis
Mild Knee Osteoarthritis
Primary: Changes in WOMAC (Western Ontario and McMaster University Osteoarthritis Index) Totol Score — 56.0; 53.3; 34.8; 31.5 Score
Phase 2 N=70 Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
Keratosis, Actinic
Primary: Lesion Clearance Rate — 88.7; 70.0; 16.7; 5.6 percentage of lesions cleared
N/A N=293 Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study
Rheumatoid Arthritis
Primary: Percentage of Participants With Remission as Per Modified American College of Rheumatology (Modified ACR) Criteria at Month 6
Phase 2 N=18 Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
Ischemic Stroke
Primary: Symptomatic Intracerebral Hemorrhage (ICH) — 1; 1 participants
Phase 1 N=12 Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
Cervical Cancer
Primary: Dose Limiting Toxicity(DLT)/Significant Dose Delay of Paclitaxel With Cisplatin as Assessed by CTC 2.0 After 6 Cycles of Treatment — 0; 0; 2; 2 participants
Phase 3 N=370 Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
Bipolar Disorder Mania
Primary: Change From Baseline in Total Score on the Young Mania Rating Scale (YMRS) (LOCF Data Set) — -11.54; -13.57 Units on a scale — p=0.058